EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Matrix Metalloproteinase‐Responsive Controlled Release of Self‐Assembly Nanoparticles Accelerates Heart Valve Regeneration In Situ by Orchestrating Immunomodulation

Xing Chen, Yunlong Wu, Peng Song, Liandong Feng, Ying Zhou, Jiawei Shi, Nianguo Dong iD, Weihua Qiao

Advanced Science · 2025-01 · 12 (2)

DOI: 10.1002/advs.202403351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.11.2024. Verfasst von Xing Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Hauptthemen laut MEDLINE: Tissue Engineering, Matrix Metalloproteinases, Heart Valve Prosthesis, Nanoparticles. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In situ tissue engineering heart valves (TEHVs) are the most promising way to overcome the defects of existing valve prostheses. Despite their promising prospects, the clinical translation of TEHVs remains a formidable challenge, mainly due to unpredictable host interactions post‐implantation. An immunomodulatory idea based on hydrogel encapsulation of nanoparticle‐coated heart valve scaffolds is introduced. Specifically, galactose‐modified human serum albumin nanoparticles (miR‐93@HSA NPs) to deliver microRNA‐93 mimics are utilized, which target macrophages and induce their differentiation into the anti‐inflammatory M2 subtype, fostering a conducive immune microenvironment. Matrix metalloproteinase (MMP)‐responsive hydrogel is used to encapsulate the nanoparticles, enabling targeted and sustained release. Results show that the miR‐93@HSA NPs exhibit excellent ability to induce macrophage polarization toward the M2 phenotype. A decellularized valve modified with hydrogel reveals MMP‐response release of the miR‐93@HSA NPs. In vitro, the immunomodulatory heart valve possesses good endocytocompatibility and effectively reprograms macrophages when cocultured with HUVECs or RAW264.7 macrophages. In vivo, this valve scaffold promises to mitigate early inflammatory damage and provide a pro‐endothelialization niche for scaffolds' constructive remodeling. With the use of cell coculture systems and transcriptome sequencing, the mechanism of immune‐modulating scaffold accelerating endothelialization is being elucidated. The immunomodulatory heart valve scaffold holds promising potential for clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue EngineeringMatrix MetalloproteinasesHeart Valve ProsthesisNanoparticlesProsthesis ImplantationHeart ValvesHydrogelsMicroRNAsMacrophagesImmunomodulationHistocompatibilityAnimalsRatsPolyethylene GlycolsRats, Sprague-DawleyMale

Stichwörter der Autor:innen

hydrogelmacrophage polarizationmicroRNAnanoparticlestissue engineering heart valves

Substanzen

Matrix MetalloproteinasesHydrogelsMIRN93 microRNA, humanMicroRNAsPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Department of Cardiovascular Surgery, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, 430071, China.
  • School of Chemistry and Engineering, Huazhong University of Science and Technology, Wuhan, Hubei, 430074, China.
  • Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases, Minda Hospital of Hubei Minzu University, Enshi, 445000, China.

ORCID-Profile: Nianguo Dong

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Chen, X., Wu, Y., Song, P., Feng, L., Zhou, Y., Shi, J., Dong, N., & Qiao, W. (2025). Matrix Metalloproteinase‐Responsive Controlled Release of Self‐Assembly Nanoparticles Accelerates Heart Valve Regeneration In Situ by Orchestrating Immunomodulation. Advanced Science, 12(2). https://doi.org/10.1002/advs.202403351

Vancouver

Chen X, Wu Y, Song P, Feng L, Zhou Y, Shi J, et al. Matrix Metalloproteinase‐Responsive Controlled Release of Self‐Assembly Nanoparticles Accelerates Heart Valve Regeneration In Situ by Orchestrating Immunomodulation. Advanced Science. 2025;12(2). doi:10.1002/advs.202403351

BibTeX
@article{Chen2025,
  author = {Chen, Xing and Wu, Yunlong and Song, Peng and Feng, Liandong and Zhou, Ying and Shi, Jiawei and Dong, Nianguo and Qiao, Weihua},
  title = {Matrix Metalloproteinase‐Responsive Controlled Release of Self‐Assembly Nanoparticles Accelerates Heart Valve Regeneration In Situ by Orchestrating Immunomodulation},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {2},
  doi = {10.1002/advs.202403351}
}
Kostenlos starten →